Acequinocyl; Pesticide Tolerances, 5409-5415 [2016-31823]
Download as PDF
mstockstill on DSK3G9T082PROD with RULES
Federal Register / Vol. 82, No. 11 / Wednesday, January 18, 2017 / Rules and Regulations
will use to determine and record the
time and cause of the alarm as well as
the corrective actions taken to minimize
emissions as specified in paragraphs
(e)(4)(i) and (ii) of this section.
*
*
*
*
*
(ii) The cause of the alarm must be
alleviated by taking the necessary
corrective action(s) that may include,
but not be limited to, those listed in
paragraphs (e)(4)(ii)(A) through (F) of
this section.
*
*
*
*
*
(h) Shop building opacity. In order to
demonstrate continuous compliance
with the opacity standards in § 63.1623,
you must comply with the requirements
§ 63.1625(d)(1) and one of the
monitoring options in paragraphs (h)(1)
or (2) of this section. The selected
option must be consistent with that
selected during the initial performance
test described in § 63.1625(d)(2).
Alternatively, you may use the
provisions of § 63.8(f) to request
approval to use an alternative
monitoring method.
*
*
*
*
*
(j) Requirements for sources using
CMS. If you demonstrate compliance
with any applicable emissions limit
through use of a continuous monitoring
system (CMS), where a CMS includes a
continuous parameter monitoring
system (CPMS) as well as a continuous
emissions monitoring system (CEMS),
you must develop a site-specific
monitoring plan and submit this sitespecific monitoring plan, if requested, at
least 60 days before your initial
performance evaluation (where
applicable) of your CMS. Your sitespecific monitoring plan must address
the monitoring system design, data
collection and the quality assurance and
quality control elements outlined in this
paragraph and in § 63.8(d). You must
install, operate and maintain each CMS
according to the procedures in your
approved site-specific monitoring plan.
Using the process described in
§ 63.8(f)(4), you may request approval of
monitoring system quality assurance
and quality control procedures
alternative to those specified in
paragraphs (j)(1) through (6) of this
section in your site-specific monitoring
plan.
*
*
*
*
*
(k) If you have an operating limit that
requires the use of a CPMS, you must
install, operate and maintain each
continuous parameter monitoring
system according to the procedures in
paragraphs (k)(1) through (7) of this
section.
*
*
*
*
*
VerDate Sep<11>2014
16:39 Jan 17, 2017
Jkt 241001
(p) Particulate Matter CEMS. If you
are using a CEMS to measure particulate
matter emissions to meet requirements
of this subpart, you must install, certify,
operate and maintain the particulate
matter CEMS as specified in paragraphs
(p)(1) through (4) of this section.
*
*
*
*
*
■ 5. Section 63.1656 is amended by
revising paragraphs (b)(7) introductory
text, (b)(7)(i) and (ii), and (b)(7)(v) to
read as follows:
§ 63.1656 Performance testing, test
methods, and compliance demonstrations.
*
*
*
*
*
(b) * * *
(7) Method 9 of appendix A–4 of 40
CFR part 60 to determine opacity.
ASTM D7520–16, ‘‘Standard Test
Method for Determining the Opacity of
a Plume in the Outdoor Ambient
Atmosphere’’ may be used (incorporated
by reference, see § 63.14) with the
following conditions:
(i) During the digital camera opacity
technique (DCOT) certification
procedure outlined in Section 9.2 of
ASTM D7520–16, the owner or operator
or the DCOT vendor must present the
plumes in front of various backgrounds
of color and contrast representing
conditions anticipated during field use
such as blue sky, trees and mixed
backgrounds (clouds and/or a sparse
tree stand).
(ii) The owner or operator must also
have standard operating procedures in
place including daily or other frequency
quality checks to ensure the equipment
is within manufacturing specifications
as outlined in Section 8.1 of ASTM
D7520–16.
*
*
*
*
*
(v) Use of this approved alternative
does not provide or imply a certification
or validation of any vendor’s hardware
or software. The onus to maintain and
verify the certification and/or training of
the DCOT camera, software and operator
in accordance with ASTM D7520–16
and these requirements is on the
facility, DCOT operator and DCOT
vendor.
*
*
*
*
*
[FR Doc. 2017–00156 Filed 1–17–17; 8:45 am]
BILLING CODE 6560–50–P
ENVIRONMENTAL PROTECTION
AGENCY
40 CFR Part 180
[EPA–HQ–OPP–2015–0829; FRL–9956–85]
Acequinocyl; Pesticide Tolerances
Environmental Protection
Agency (EPA).
AGENCY:
PO 00000
Frm 00075
Fmt 4700
Sfmt 4700
ACTION:
5409
Final rule.
This regulation establishes
tolerances for residues of acequinocyl in
or on multiple commodities which are
identified and discussed later in this
document. Interregional Project Number
4 (IR–4) requested these tolerances
under the Federal Food, Drug, and
Cosmetic Act (FFDCA).
DATES: This regulation is effective
January 18, 2017. Objections and
requests for hearings must be received
on or before March 20, 2017, and must
be filed in accordance with the
instructions provided in 40 CFR part
178 (see also Unit I.C. of the
SUPPLEMENTARY INFORMATION).
ADDRESSES: The docket for this action,
identified by docket identification (ID)
number EPA–HQ–OPP–2015–0829, is
available at https://www.regulations.gov
or at the Office of Pesticide Programs
Regulatory Public Docket (OPP Docket)
in the Environmental Protection Agency
Docket Center (EPA/DC), West William
Jefferson Clinton Bldg., Rm. 3334, 1301
Constitution Ave. NW., Washington, DC
20460–0001. The Public Reading Room
is open from 8:30 a.m. to 4:30 p.m.,
Monday through Friday, excluding legal
holidays. The telephone number for the
Public Reading Room is (202) 566–1744,
and the telephone number for the OPP
Docket is (703) 305–5805. Please review
the visitor instructions and additional
information about the docket available
at https://www.epa.gov/dockets.
FOR FURTHER INFORMATION CONTACT:
Michael Goodis, Registration Division
(7505P), Office of Pesticide Programs,
Environmental Protection Agency, 1200
Pennsylvania Ave. NW., Washington,
DC 20460–0001; main telephone
number: (703) 305–7090; email address:
RDFRNotices@epa.gov.
SUPPLEMENTARY INFORMATION:
SUMMARY:
I. General Information
A. Does this action apply to me?
You may be potentially affected by
this action if you are an agricultural
producer, food manufacturer, or
pesticide manufacturer. The following
list of North American Industrial
Classification System (NAICS) codes is
not intended to be exhaustive, but rather
provides a guide to help readers
determine whether this document
applies to them. Potentially affected
entities may include:
• Crop production (NAICS code 111).
• Animal production (NAICS code
112).
• Food manufacturing (NAICS code
311).
• Pesticide manufacturing (NAICS
code 32532).
E:\FR\FM\18JAR1.SGM
18JAR1
5410
Federal Register / Vol. 82, No. 11 / Wednesday, January 18, 2017 / Rules and Regulations
B. How can I get electronic access to
other related information?
II. Summary of Petitioned-For
Tolerance
You may access a frequently updated
electronic version of EPA’s tolerance
regulations at 40 CFR part 180 through
the Government Printing Office’s e-CFR
site at https://www.ecfr.gov/cgi-bin/textidx?&c=ecfr&tpl=/ecfrbrowse/Title40/
40tab_02.tpl.
In the Federal Register of May 19,
2016 (81 FR 31581) (FRL–9946–02),
EPA issued a document pursuant to
FFDCA section 408(d)(3), 21 U.S.C.
346a(d)(3), announcing the filing of a
pesticide petition (PP 5E8422) by
Interregional Research Project Number 4
(IR–4), Rutgers University, 500 College
Rd. East, Suite 201 W, Princeton, NJ
08540. The petition requested that 40
CFR 180.599 be amended by
establishing tolerances for residues of
the insecticide acequinocyl in or on
avocado at 0.4 parts per million (ppm);
bean, dry, seed at 0.03 ppm; vegetable,
cucurbit, group 9 at 0.2 ppm; tea,
plucked leaves at 40 ppm; cherry
subgroup 12–12A at 1.0 ppm; fruit,
citrus, group 10–10 at 0.20 ppm; fruit,
pome, group 11–10 at 0.40 ppm; nut,
tree, group 14–12 at 0.02 ppm; and
vegetable, fruiting, group 8–10 at 0.70
ppm. The petition also requested that
upon establishment of the above
tolerances, to remove the existing
tolerances for cucumber at 0.15 ppm;
melon, subgroup 9A at 0.15 ppm;
cherry, sweet at 0.50 ppm; cherry, tart
at 1.0 ppm; fruit, citrus, group 10 at 0.20
ppm; fruit, pome, group 11 at 0.40 ppm;
nut, tree, group 14 at 0.02 ppm;
pistachio at 0.02 ppm; vegetable,
fruiting, group 8 at 0.70 ppm; and okra
at 0.70 ppm. That document referenced
a summary of the petition prepared by
Arysta LifeScience, the registrant, which
is available in the docket, https://
www.regulations.gov. Comments were
received on the notice of filing. EPA’s
response to these comments is
discussed in Unit IV.C.
Based upon review of the data
supporting the petition, EPA has
modified the levels at which some of the
tolerances are being established. The
reason for these changes is explained in
Unit IV.D.
mstockstill on DSK3G9T082PROD with RULES
C. How can I file an objection or hearing
request?
Under FFDCA section 408(g), 21
U.S.C. 346a, any person may file an
objection to any aspect of this regulation
and may also request a hearing on those
objections. You must file your objection
or request a hearing on this regulation
in accordance with the instructions
provided in 40 CFR part 178. To ensure
proper receipt by EPA, you must
identify docket ID number EPA–HQ–
OPP–2015–0829 in the subject line on
the first page of your submission. All
objections and requests for a hearing
must be in writing, and must be
received by the Hearing Clerk on or
before March 20, 2017. Addresses for
mail and hand delivery of objections
and hearing requests are provided in 40
CFR 178.25(b).
In addition to filing an objection or
hearing request with the Hearing Clerk
as described in 40 CFR part 178, please
submit a copy of the filing (excluding
any Confidential Business Information
(CBI)) for inclusion in the public docket.
Information not marked confidential
pursuant to 40 CFR part 2 may be
disclosed publicly by EPA without prior
notice. Submit the non-CBI copy of your
objection or hearing request, identified
by docket ID number EPA–HQ–OPP–
2015–0829, by one of the following
methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the online
instructions for submitting comments.
Do not submit electronically any
information you consider to be CBI or
other information whose disclosure is
restricted by statute.
• Mail: OPP Docket, Environmental
Protection Agency Docket Center (EPA/
DC), (28221T), 1200 Pennsylvania Ave.
NW., Washington, DC 20460–0001.
• Hand Delivery: To make special
arrangements for hand delivery or
delivery of boxed information, please
follow the instructions at https://
www.epa.gov/dockets/contacts.html.
Additional instructions on
commenting or visiting the docket,
along with more information about
dockets generally, is available at https://
www.epa.gov/dockets.
VerDate Sep<11>2014
16:39 Jan 17, 2017
Jkt 241001
III. Aggregate Risk Assessment and
Determination of Safety
Section 408(b)(2)(A)(i) of FFDCA
allows EPA to establish a tolerance (the
legal limit for a pesticide chemical
residue in or on a food) only if EPA
determines that the tolerance is ‘‘safe.’’
Section 408(b)(2)(A)(ii) of FFDCA
defines ‘‘safe’’ to mean that ‘‘there is a
reasonable certainty that no harm will
result from aggregate exposure to the
pesticide chemical residue, including
all anticipated dietary exposures and all
other exposures for which there is
reliable information.’’ This includes
exposure through drinking water and in
residential settings, but does not include
occupational exposure. Section
PO 00000
Frm 00076
Fmt 4700
Sfmt 4700
408(b)(2)(C) of FFDCA requires EPA to
give special consideration to exposure
of infants and children to the pesticide
chemical residue in establishing a
tolerance and to ‘‘ensure that there is a
reasonable certainty that no harm will
result to infants and children from
aggregate exposure to the pesticide
chemical residue. . . .’’
Consistent with FFDCA section
408(b)(2)(D), and the factors specified in
FFDCA section 408(b)(2)(D), EPA has
reviewed the available scientific data
and other relevant information in
support of this action. EPA has
sufficient data to assess the hazards of
and to make a determination on
aggregate exposure for acequinocyl
including exposure resulting from the
tolerances established by this action.
EPA’s assessment of exposures and risks
associated with acequinocyl follows.
A. Toxicological Profile
EPA has evaluated the available
toxicity data and considered its validity,
completeness, and reliability as well as
the relationship of the results of the
studies to human risk. EPA has also
considered available information
concerning the variability of the
sensitivities of major identifiable
subgroups of consumers, including
infants and children.
The target organs of acequinocyl are
the liver (hepatocyte vacuolization,
brown pigmented cells and perivascular
inflammatory cells in liver) and
hematopoietic system (hemorrhage,
increased clotting factor times and
increased platelet counts). There was no
evidence of neurotoxicity and
immunotoxicity and there was no
evidence of carcinogenic potential in
either the rat or mouse, or in the
genotoxicity and mutagenicity studies.
In rats and rabbits, there was no
evidence of increased quantitative or
qualitative fetal susceptibility. In both
species there were clinical signs and
gross necropsy findings seen in
maternal animals at similar or lower
doses than those producing resorptions.
In rabbits, there were increased
incidences of late resorptions at the
highest dose tested. In the rat twogeneration reproductive toxicity study,
there was evidence of apparent
increased quantitative postnatal
susceptibility. Offspring effects at the
mid- and high-doses consisted of
swollen body parts, protruding eyes,
clinical signs, delays in pupil
development, and increased mortality
occurring mainly after weaning. No
parental effects were observed up to the
highest dose tested; however,
hematological parameters, such as
changes in partial and activated partial
E:\FR\FM\18JAR1.SGM
18JAR1
Federal Register / Vol. 82, No. 11 / Wednesday, January 18, 2017 / Rules and Regulations
thromboplastin times, were not
measured in parental animals and
changes in these parameters would have
been expected at the same doses as
offspring effects based on rat studies in
the acequinocyl toxicological database.
There were no effects on reproductive
parameters.
Specific information on the studies
received and the nature of the adverse
effects caused by acequinocyl as well as
the no-observed-adverse-effect-level
(NOAEL) and the lowest-observedadverse-effect-level (LOAEL) from the
toxicity studies can be found at https://
www.regulations.gov in the document
titled ‘‘Acequinocyl. Human Health Risk
Assessment To Support the Petition for
Tolerance for Residues in/on Dry Beans,
Cucurbit Vegetables, Group 9, Avocado
and Tea (Without U.S. Registration) and
Crop Group Conversions for Citrus Fruit
Group 10–10, Tree Nut Group 14–12,
and Fruiting Vegetable Group 8–10’’ at
page 30 in docket ID number EPA–HQ–
OPP–2015–0829.
B. Toxicological Points of Departure/
Levels of Concern
Once a pesticide’s toxicological
profile is determined, EPA identifies
toxicological points of departure (POD)
and levels of concern to use in
evaluating the risk posed by human
exposure to the pesticide. For hazards
that have a threshold below which there
is no appreciable risk, the toxicological
POD is used as the basis for derivation
of reference values for risk assessment.
PODs are developed based on a careful
analysis of the doses in each
toxicological study to determine the
dose at which no adverse effects are
observed (the NOAEL) and the lowest
dose at which adverse effects of concern
are identified (the LOAEL). Uncertainty/
safety factors are used in conjunction
with the POD to calculate a safe
exposure level—generally referred to as
a population-adjusted dose (PAD) or a
reference dose (RfD)—and a safe margin
of exposure (MOE). For non-threshold
risks, the Agency assumes that any
5411
amount of exposure will lead to some
degree of risk. Thus, the Agency
estimates risk in terms of the probability
of an occurrence of the adverse effect
expected in a lifetime. For more
information on the general principles
EPA uses in risk characterization and a
complete description of the risk
assessment process, see https://
www2.epa.gov/pesticide-science-andassessing-pesticide-risks/assessinghuman-health-risk-pesticides.
Since the last assessment for
acequinocyl (Federal Register of April
13, 2016, (81 FR 21752) (FRL–9944–
34)), the endpoints for acequinocyl were
revisited and updated based upon the
available data. An acute dietary
endpoint for the general population has
been selected to be consistent with
current Agency practices. A summary of
the updated toxicological endpoints for
acequinocyl used for human risk
assessment is shown in Table 1 of this
unit.
TABLE 1—SUMMARY OF TOXICOLOGICAL DOSES AND ENDPOINTS FOR ACEQUINOCYL FOR USE IN HUMAN HEALTH RISK
ASSESSMENT
Exposure/scenario
Point of departure
and uncertainty/safety factors
RfD, PAD, LOC for
risk assessment
Acute dietary (General population including infants and
children).
NOAEL = 7.3 mg/kg/
day UFA = 10×.
UFH = 10×
FQPA SF = 1×
Chronic dietary (All populations)
NOAEL = 2.7 mg/kg/ Chronic RfD = 0.027
day UFA = 10×.
mg/kg/day.
UFH = 10×
cPAD = 0.027 mg/
FQPA SF = 1×
kg/day
Dermal study
LOC for MOE = 100
NOAEL = 200 mg/
kg/day.
UFA = 10×
UFH = 10×
FQPA SF = 1×
Classification: Not likely to be carcinogenic to
Dermal short-term (1 to 30
days).
Cancer (Oral, dermal, inhalation).
Acute RfD = 0.073
mg/kg/day.
aPAD = 0.073 mg/
kg/day
Study and toxicological effects
Reproduction and fertility effects in rats Offspring LOAEL (M/F)
= 58.9 based on hemorrhagic effects, swollen body parts,
protruding eyes, clinical signs, delays in pupil development
and increased mortality post weaning.
18-month carcinogenicity study in mice; LOAEL = 7.0 mg/kg/
day based on clinical chemistry and microscopic non-neoplastic lesions (brown pigmented cells and perivascular inflammatory cells in liver).
28-dermal toxicity in rats.
LOAEL (M/F) = 1000 mg/kg/day based on increased clotting
factor times in males.
humans.
FQPA SF = Food Quality Protection Act Safety Factor. LOAEL = lowest-observed-adverse-effect-level. LOC = level of concern. mg/kg/day =
milligram/kilogram/day. MOE = margin of exposure. NOAEL = no-observed-adverse-effect-level. PAD = population-adjusted dose (a = acute, c =
chronic). RfD = reference dose. UF = uncertainty factor. UFA = extrapolation from animal to human (interspecies). UFH = potential variation in
sensitivity among members of the human population (intraspecies).
mstockstill on DSK3G9T082PROD with RULES
C. Exposure Assessment
1. Dietary exposure from food and
feed uses. In evaluating dietary
exposure to acequinocyl, EPA
considered exposure under the
petitioned-for tolerances as well as all
existing acequinocyl tolerances in 40
CFR 180.599. EPA assessed dietary
exposures from acequinocyl in food as
follows:
i. Acute exposure. Quantitative acute
dietary exposure and risk assessments
are performed for a food-use pesticide,
VerDate Sep<11>2014
16:39 Jan 17, 2017
Jkt 241001
if a toxicological study has indicated the
possibility of an effect of concern
occurring as a result of a 1-day or single
exposure.
Such effects were identified for
acequinocyl. In estimating acute dietary
exposure, EPA used food consumption
information from the United States
Department of Agriculture (USDA)
2003–2008 National Health and
Nutrition Examination Survey, What We
Eat in America, (NHANES/WWEIA). As
to residue levels in food, EPA assumed
tolerance level residues and 100 percent
PO 00000
Frm 00077
Fmt 4700
Sfmt 4700
crop treated (PCT) for all proposed and
registered uses.
ii. Chronic exposure. In conducting
the chronic dietary exposure assessment
EPA used the food consumption data
from the USDA 2003–2008 NHANES/
WWEIA. As to residue levels in food,
EPA assumed tolerance level residues
and 100 PCT for all proposed and
registered uses.
iii. Cancer. Based on the data
summarized in Unit III.A., EPA has
concluded that acequinocyl does not
pose a cancer risk to humans. Therefore,
E:\FR\FM\18JAR1.SGM
18JAR1
mstockstill on DSK3G9T082PROD with RULES
5412
Federal Register / Vol. 82, No. 11 / Wednesday, January 18, 2017 / Rules and Regulations
a dietary exposure assessment for the
purpose of assessing cancer risk is
unnecessary.
iv. Anticipated residue and PCT
information. EPA did not use
anticipated residue or PCT information
in the dietary assessment for
acequinocyl. Tolerance level residues
and 100 PCT were assumed for all food
commodities.
2. Dietary exposure from drinking
water. The Agency used screening level
water exposure models in the dietary
exposure analysis and risk assessment
for acequinocyl in drinking water. These
simulation models take into account
data on the physical, chemical, and fate/
transport characteristics of acequinocyl.
Further information regarding EPA
drinking water models used in pesticide
exposure assessment can be found at
https://www2.epa.gov/pesticide-scienceand-assessing-pesticide-risks/aboutwater-exposure-models-used-pesticide.
Based on the Pesticide Root Zone
Model/Exposure Analysis Modeling
System (PRZM/EXAMS), Provisional
Cranberry Model, and Screening
Concentration in Ground Water (SCI–
GROW) Model, the estimated drinking
water concentrations (EDWCs) of
acequinocyl for acute exposures are
estimated to be 6.69 parts per billion
(ppb) for surface water and 3.6 × 10¥3
ppb for ground water, and for chronic
exposures are estimated to be 6.69 ppb
for surface water and ≥3.6 × 10¥3 ppb
for ground water.
Modeled estimates of drinking water
concentrations were directly entered
into the dietary exposure model. For
acute dietary risk assessment, the water
concentration value of 6.69 ppb was
used to assess the contribution to
drinking water. For chronic dietary risk
assessment, the water concentration of
value 6.69 ppb was used to assess the
contribution to drinking water.
3. From non-dietary exposure. The
term ‘‘residential exposure’’ is used in
this document to refer to nonoccupational, non-dietary exposure
(e.g., for lawn and garden pest control,
indoor pest control, termiticides, and
flea and tick control on pets).
Acequinocyl is currently registered
for the following uses that could result
in residential exposures: use on
ornamentals for landscapes, gardens,
and trees. EPA assessed residential
exposure using the following
assumptions: There is a potential for
residential exposure associated with
handler (i.e., mixing, loading and
applying); however, all registered
acequinocyl product labels with
residential use sites (e.g., ornamentals
for landscapes, gardens, and trees)
require that handlers wear specific
VerDate Sep<11>2014
16:39 Jan 17, 2017
Jkt 241001
clothing (e.g., long-sleeve shirt/long
pants) and/or use personal protective
equipment (PPE). Therefore, the Agency
has made the assumption that these
products are not for homeowner use,
and has not conducted a quantitative
residential handler assessment.
Only short-term post-application
dermal exposure is anticipated for the
registered residential uses. The
quantitative exposure/risk assessment
for residential post-application
exposures assessed dermal exposures to
adults for activities associated with
gardening, dermal exposures to children
(6 to <11 years old) for activities
associated with playing in and around
gardens and gardening, dermal
exposures to adults associated with
handling trees and retail plants, and
dermal exposures to children (6 to <11
years old) for activities associated with
playing in and around trees and retail
plants.
Further information regarding EPA
standard assumptions and generic
inputs for residential exposures may be
found at https://www2.epa.gov/pesticidescience-and-assessing-pesticide-risks/
standard-operating-proceduresresidential-pesticide.
4. Cumulative effects from substances
with a common mechanism of toxicity.
Section 408(b)(2)(D)(v) of FFDCA
requires that, when considering whether
to establish, modify, or revoke a
tolerance, the Agency consider
‘‘available information’’ concerning the
cumulative effects of a particular
pesticide’s residues and ‘‘other
substances that have a common
mechanism of toxicity.’’
EPA has not found acequinocyl to
share a common mechanism of toxicity
with any other substances, and
acequinocyl does not appear to produce
a toxic metabolite produced by other
substances. For the purposes of this
tolerance action, therefore, EPA has
assumed that acequinocyl does not have
a common mechanism of toxicity with
other substances. For information
regarding EPA’s efforts to determine
which chemicals have a common
mechanism of toxicity and to evaluate
the cumulative effects of such
chemicals, see EPA’s Web site at https://
www2.epa.gov/pesticide-science-andassessing-pesticide-risks/cumulativeassessment-risk-pesticides.
D. Safety Factor for Infants and
Children
1. In general. Section 408(b)(2)(C) of
FFDCA provides that EPA shall apply
an additional tenfold (10X) margin of
safety for infants and children in the
case of threshold effects to account for
prenatal and postnatal toxicity and the
PO 00000
Frm 00078
Fmt 4700
Sfmt 4700
completeness of the database on toxicity
and exposure unless EPA determines
based on reliable data that a different
margin of safety will be safe for infants
and children. This additional margin of
safety is commonly referred to as the
FQPA Safety Factor (SF). In applying
this provision, EPA either retains the
default value of 10X, or uses a different
additional safety factor when reliable
data available to EPA support the choice
of a different factor.
2. Prenatal and postnatal sensitivity.
There is no evidence of an increased
quantitative or qualitative fetal
susceptibility in rats or rabbits. In
isolation, there was evidence of
increased quantitative offspring
susceptibility in the two-generation
reproductive study; however, but the
concern is low since: (1) The effects in
pups are well characterized with a clear
NOAEL; and (2) the effects are protected
for by the selected endpoints. Therefore,
there are no residual uncertainties for
pre-/post-natal toxicity. Additionally,
taking into consideration the full
database, there would be no
susceptibility to offspring since
assessment of parental animals in the
two-generation reproductive toxicity
study were limited. If additional
evaluations had been performed,
including all hematological
measurements, then it would be
expected that effects on the
hematopoietic system observed in the
other oral rat studies would have been
seen at the same doses eliciting
offspring effects. Therefore, using a
weight-of-evidence approach that puts
the offspring findings in the twogeneration reproductive toxicity study
in context with the full toxicological
database, there is no concern for
susceptibility to offspring since parental
toxicity would be anticipated at the
same dose as offspring effects.
3. Conclusion. EPA has determined
that reliable data show the safety of
infants and children would be
adequately protected if the FQPA SF
were reduced to 1x. That decision is
based on the following findings:
i. The toxicity database for
acequinocyl is complete.
ii. There is no indication that
acequinocyl is a neurotoxic chemical
and there is no need for a
developmental neurotoxicity study or
additional UFs to account for
neurotoxicity.
iii. There is no evidence of an
increased quantitative or qualitative
fetal susceptibility in rats or rabbits, but
in isolation there was evidence of
increased quantitative offspring
susceptibility in the two-generation
reproductive study. However, the
E:\FR\FM\18JAR1.SGM
18JAR1
Federal Register / Vol. 82, No. 11 / Wednesday, January 18, 2017 / Rules and Regulations
mstockstill on DSK3G9T082PROD with RULES
concern is low for the reasons outlined
above in section III.D.2.
iv. There are no residual uncertainties
identified in the exposure databases.
The dietary food exposure assessments
were performed based on 100 PCT and
tolerance-level residues. EPA made
conservative (protective) assumptions in
the ground and surface water modeling
used to assess exposure to acequinocyl
in drinking water. EPA used similarly
conservative assumptions to assess postapplication exposure of children. These
assessments will not underestimate the
exposure and risks posed by
acequinocyl.
E. Aggregate Risks and Determination of
Safety
EPA determines whether acute and
chronic dietary pesticide exposures are
safe by comparing aggregate exposure
estimates to the acute PAD (aPAD) and
chronic PAD (cPAD). For linear cancer
risks, EPA calculates the lifetime
probability of acquiring cancer given the
estimated aggregate exposure. Short-,
intermediate-, and chronic-term risks
are evaluated by comparing the
estimated aggregate food, water, and
residential exposure to the appropriate
PODs to ensure that an adequate MOE
exists.
1. Acute risk. Using the exposure
assumptions discussed in this unit for
acute exposure, the acute dietary
exposure from food and water to
acequinocyl will occupy 71% of the
aPAD for children 1–2 years old, the
population group receiving the greatest
exposure.
2. Chronic risk. Using the exposure
assumptions described in this unit for
chronic exposure, EPA has concluded
that chronic exposure to acequinocyl
from food and water will utilize 70% of
the cPAD for children 1–2 years old, the
population group receiving the greatest
exposure. Based on the explanation in
Unit III.C.3., regarding residential use
patterns, chronic residential exposure to
residues of acequinocyl is not expected.
3. Short-term risk. Short-term
aggregate exposure takes into account
short-term residential exposure plus
chronic exposure to food and water
(considered to be a background
exposure level). Acequinocyl is
currently registered for uses that could
result in short-term residential
exposure, and the Agency has
determined that it is appropriate to
aggregate chronic exposure through food
and water with short-term residential
exposures to acequinocyl.
Using the exposure assumptions
described in this unit for short-term
exposures, EPA has concluded the
combined short-term food, water, and
VerDate Sep<11>2014
16:39 Jan 17, 2017
Jkt 241001
residential exposures result in aggregate
MOEs of 1200 for adults and 890 for
children 6–12 years old. Because EPA’s
level of concern for acequinocyl is a
MOE of 100 or below, these MOEs are
not of concern.
4. Intermediate-term risk.
Intermediate-term aggregate exposure
takes into account intermediate-term
residential exposure plus chronic
exposure to food and water (considered
to be a background exposure level).
An intermediate-term adverse effect
was identified; however, acequinocyl is
not registered for any use patterns that
would result in intermediate-term
residential exposure. Intermediate-term
risk is assessed based on intermediateterm residential exposure plus chronic
dietary exposure. Because there is no
intermediate-term residential exposure
and chronic dietary exposure has
already been assessed under the
appropriately protective cPAD (which is
at least as protective as the POD used to
assess intermediate-term risk), no
further assessment of intermediate-term
risk is necessary, and EPA relies on the
chronic dietary risk assessment for
evaluating intermediate-term risk for
acequinocyl.
5. Aggregate cancer risk for U.S.
population. Based on the lack of
evidence of carcinogenicity in two
adequate rodent carcinogenicity studies,
acequinocyl is not expected to pose a
cancer risk to humans.
6. Determination of safety. Based on
these risk assessments, EPA concludes
that there is a reasonable certainty that
no harm will result to the general
population, or to infants and children
from aggregate exposure to acequinocyl
residues.
IV. Other Considerations
A. Analytical Enforcement Methodology
Adequate enforcement methodology
(two high-performance liquid
chromatography methods with tandem
mass-spectroscopy detection (HPLC/
MS/MS) for determining residues in/on
fruit and nut commodities (Morse
Methods Meth-133 and Meth-135) is
available to enforce the tolerance
expression.
The method may be requested from:
Chief, Analytical Chemistry Branch,
Environmental Science Center, 701
Mapes Rd., Ft. Meade, MD 20755–5350;
telephone number: (410) 305–2905;
email address: residuemethods@
epa.gov.
B. International Residue Limits
In making its tolerance decisions, EPA
seeks to harmonize U.S. tolerances with
international standards whenever
PO 00000
Frm 00079
Fmt 4700
Sfmt 4700
5413
possible, consistent with U.S. food
safety standards and agricultural
practices. EPA considers the
international maximum residue limits
(MRLs) established by the Codex
Alimentarius Commission (Codex), as
required by FFDCA section 408(b)(4).
The Codex Alimentarius is a joint
United Nations Food and Agriculture
Organization/World Health
Organization food standards program,
and it is recognized as an international
food safety standards-setting
organization in trade agreements to
which the United States is a party. EPA
may establish a tolerance that is
different from a Codex MRL; however,
FFDCA section 408(b)(4) requires that
EPA explain the reasons for departing
from the Codex level.
The Codex has not established any
MRLs for acequinocyl.
C. Response to Comments
A comment was submitted by the
Center for Biological Diversity and was
primarily concerned about EPA’s
consideration of the impacts of
acequinocyl on the environment,
pollinators, and endangered species.
This comment is not relevant to the
Agency’s evaluation of safety of the
acequinocyl tolerances under section
408 of the FFDCA, which requires the
Agency to evaluate the potential harms
to human health, not effects on the
environment.
Two other comments were submitted
in response to the Notice of Filing that
stated, in part, that this chemical
‘‘should not be used at all in America
or anywhere in the world’’ and that ‘‘no
residue should be permitted on any food
or other plant.’’ The Agency
understands the commenter’s concerns
and recognizes that some individuals
believe that pesticides should be banned
on agricultural crops. However, the
existing legal framework provided by
section 408 of the FFDCA states that
tolerances may be set when persons
seeking such tolerances or exemptions
have demonstrated that the pesticide
meets the safety standard imposed by
that statute. The citizens’ comments
appear to be directed at the underlying
statute and not EPA’s implementation of
it; the citizens have made no contention
that EPA has acted in violation of the
statutory framework.
D. Revisions to Petitioned-For
Tolerances
The petitioned-for tolerance of 0.4 for
residues on avocado is being increased
to 0.50 ppm as EPA corrected some
residue levels in the field trials for
degradation during storage and declared
two of the trials to be replicates. The
E:\FR\FM\18JAR1.SGM
18JAR1
5414
Federal Register / Vol. 82, No. 11 / Wednesday, January 18, 2017 / Rules and Regulations
data that EPA used in Organization for
Economic Co-operation and
Development (OECD) Maximum
Residue Limits (MRL) Tolerance
Worksheet for avocado was thus slightly
different from the petitioner’s data. The
tolerance level of 0.15 ppm for residues
in dry beans is based upon the OECD
MRL tolerance worksheet. The
difference is based on EPA using
slightly different residue levels that
were corrected for degradation during
storage. The tolerance level of 0.30 ppm
for residues in/on cucurbit vegetables is
based upon the OECD MRL tolerance
worksheet. The difference is based on
EPA using slightly different residue
levels that were corrected for
degradation during storage. The data
that EPA used in MRL tolerance
spreadsheet for summer squash was
slightly different from the petitioner’s
data. Concerning the crop group
conversions, the tolerance level for
residues in/on citrus fruit was modified
to be harmonized with the Canadian
MRL.
mstockstill on DSK3G9T082PROD with RULES
V. Conclusion
Therefore, tolerances are established
for residues of acequinocyl, including
its metabolites and degradates, in or on
avocado at 0.50 ppm; bean, dry, seed at
0.15 ppm; cherry, subgroup 12–12A at
1.0 ppm; fruit, citrus, group 10–10 at
0.35 ppm; fruit, pome, group 11–10 at
0.40 ppm; nut, tree, group 14–12 at 0.02
ppm; tea, plucked leaves at 40 ppm;
vegetable, cucurbit, group 9 at 0.30
ppm; and vegetable, fruiting, group 8–10
at 0.70 ppm. In addition, the existing
tolerances on cherry, sweet; cherry, tart;
cucumber; fruit, citrus, group 10; fruit,
pome, group 11; melon, subgroup 9A;
nut, tree, group 14; okra; pistachio; and
vegetable, fruiting, group 8 are removed
as unnecessary since they are now
covered by the new tolerances.
VI. Statutory and Executive Order
Reviews
This action establishes tolerances
under FFDCA section 408(d) in
response to a petition submitted to the
Agency. The Office of Management and
Budget (OMB) has exempted these types
of actions from review under Executive
Order 12866, entitled ‘‘Regulatory
Planning and Review’’ (58 FR 51735,
October 4, 1993). Because this action
has been exempted from review under
Executive Order 12866, this action is
not subject to Executive Order 13211,
entitled ‘‘Actions Concerning
Regulations That Significantly Affect
Energy Supply, Distribution, or Use’’ (66
FR 28355, May 22, 2001) or Executive
Order 13045, entitled ‘‘Protection of
Children from Environmental Health
VerDate Sep<11>2014
16:39 Jan 17, 2017
Jkt 241001
Risks and Safety Risks’’ (62 FR 19885,
April 23, 1997). This action does not
contain any information collections
subject to OMB approval under the
Paperwork Reduction Act (PRA) (44
U.S.C. 3501 et seq.), nor does it require
any special considerations under
Executive Order 12898, entitled
‘‘Federal Actions to Address
Environmental Justice in Minority
Populations and Low-Income
Populations’’ (59 FR 7629, February 16,
1994).
Since tolerances and exemptions that
are established on the basis of a petition
under FFDCA section 408(d), such as
the tolerance in this final rule, do not
require the issuance of a proposed rule,
the requirements of the Regulatory
Flexibility Act (RFA) (5 U.S.C. 601 et
seq.), do not apply.
This action directly regulates growers,
food processors, food handlers, and food
retailers, not States or tribes, nor does
this action alter the relationships or
distribution of power and
responsibilities established by Congress
in the preemption provisions of FFDCA
section 408(n)(4). As such, the Agency
has determined that this action will not
have a substantial direct effect on States
or tribal governments, on the
relationship between the national
government and the States or tribal
governments, or on the distribution of
power and responsibilities among the
various levels of government or between
the Federal Government and Indian
tribes. Thus, the Agency has determined
that Executive Order 13132, entitled
‘‘Federalism’’ (64 FR 43255, August 10,
1999) and Executive Order 13175,
entitled ‘‘Consultation and Coordination
with Indian Tribal Governments’’ (65 FR
67249, November 9, 2000) do not apply
to this action. In addition, this action
does not impose any enforceable duty or
contain any unfunded mandate as
described under Title II of the Unfunded
Mandates Reform Act (UMRA) (2 U.S.C.
1501 et seq.).
This action does not involve any
technical standards that would require
Agency consideration of voluntary
consensus standards pursuant to section
12(d) of the National Technology
Transfer and Advancement Act
(NTTAA) (15 U.S.C. 272 note).
VII. Congressional Review Act
Pursuant to the Congressional Review
Act (5 U.S.C. 801 et seq.), EPA will
submit a report containing this rule and
other required information to the U.S.
Senate, the U.S. House of
Representatives, and the Comptroller
General of the United States prior to
publication of the rule in the Federal
PO 00000
Frm 00080
Fmt 4700
Sfmt 4700
Register. This action is not a ‘‘major
rule’’ as defined by 5 U.S.C. 804(2).
List of Subjects in 40 CFR Part 180
Environmental protection,
Administrative practice and procedure,
Agricultural commodities, Pesticides
and pests, Reporting and recordkeeping
requirements.
Dated: December 15, 2016.
Daniel J. Rosenblatt,
Acting Director, Registration Division, Office
of Pesticide Programs.
Therefore, 40 CFR chapter I is
amended as follows:
PART 180—[AMENDED]
1. The authority citation for part 180
continues to read as follows:
■
Authority: 21 U.S.C. 321(q), 346a and 371.
2. In § 180.599, in the table in
paragraph (a);
■ a. Add alphabetically the entries
‘‘Avocado’’; ‘‘Bean, dry, seed’’; ‘‘Cherry,
subgroup 12–12A’’; ‘‘Fruit, citrus, group
10–10’’; ‘‘Fruit, pome, group 11–10’’;
‘‘Nut, tree, group 14–12’’; ‘‘Tea, plucked
leaves’’ (and a footnote); ‘‘Vegetable,
cucurbit, group 9’’; and ‘‘Vegetable,
fruiting, group 8–10’’; and
■ b. Remove the entries for ‘‘cherry,
sweet’’; ‘‘cherry, tart’’; ‘‘cucumber’’;
‘‘fruit, citrus, group 10’’; ‘‘fruit, pome,
group 11’’; ‘‘melon, subgroup 9A’’; ‘‘nut,
tree, group 14’’; ‘‘okra’’; ‘‘pistachio’’;
and ‘‘vegetable, fruiting, group 8’’ from
the table in paragraph (a).
The additions read as follows:
■
§ 180.599 Acequinocyl; tolerances for
residues.
(a) * * *
Commodity
Parts per
million
*
*
*
Avocado ....................................
Bean, dry, seed ........................
*
*
*
*
Cherry, subgroup 12–12A ........
*
*
*
*
Fruit, citrus, group 10–10 .........
Fruit, pome, group 11–10 .........
*
*
*
*
Nut, tree, group 14–12 .............
*
*
*
*
Tea, plucked leaves 1 ...............
Vegetable, cucurbit, group 9 ....
Vegetable, fruiting, group 8–10
*
0.50
0.15
1.0
0.35
0.40
0.02
40
0.30
0.70
1 There are no U.S. registrations as of January 18, 2017 for use on tea.
E:\FR\FM\18JAR1.SGM
18JAR1
Federal Register / Vol. 82, No. 11 / Wednesday, January 18, 2017 / Rules and Regulations
This rule finalizes changes to
the pass-through payment transition
periods and the maximum amount of
pass-through payments permitted
annually during the transition periods
under Medicaid managed care
contract(s) and rate certification(s). This
final rule prevents increases in passthrough payments and the addition of
new pass-through payments beyond
those in place when the pass-through
payment transition periods were
established, in the final Medicaid
managed care regulations effective July
5, 2016.
DATES: Effective Date: These regulations
are effective on March 20, 2017.
FOR FURTHER INFORMATION CONTACT: John
Giles, (410) 786–1255.
SUPPLEMENTARY INFORMATION:
inpatient health plan’s (PIHP’s), or
prepaid ambulatory health plan’s
(PAHP’s) expenditures under the
contract.
In the May 6, 2016 Federal Register
(81 FR 27498), we published the
‘‘Medicaid and Children’s Health
Insurance Program (CHIP) Programs;
Medicaid Managed Care, CHIP
Delivered in Managed Care, and
Revisions Related to Third Party
Liability’’ final rule (‘‘May 6, 2016 final
rule’’), which finalized the June 1, 2015
proposed rule. In the final rule, we
finalized, with some revisions, the
proposal which limited state direction
of payments, including pass-through
payments as defined below.
In the November 22, 2016 Federal
Register (81 FR 83777), we published
the ‘‘Medicaid Program; The Use of New
or Increased Pass-Through Payments in
Medicaid Managed Care Delivery
Systems’’ proposed rule (‘‘November 22,
2016 proposed rule’’). This rule finalizes
the November 22, 2016 proposed rule as
discussed below. This final rule is
consistent with the intent of the May 6,
2016 final rule to provide transition
periods for states that already use passthrough payments—these transition
periods allow states to implement
changes to existing pass-through
payments over a period of time to
minimize disruption and to ensure
continued financial support for safetynet providers. As we discussed in the
November 22, 2016 proposed rule, this
final rule is also consistent with the
CMCS Informational Bulletin (CIB)
concerning ‘‘The Use of New or
Increased Pass-Through Payments in
Medicaid Managed Care Delivery
Systems,’’ which was published on July
29, 2016.
I. Background
In the June 1, 2015 Federal Register
(80 FR 31098), we published the
‘‘Medicaid and Children’s Health
Insurance Program (CHIP) Programs;
Medicaid Managed Care, CHIP
Delivered in Managed Care, Medicaid
and CHIP Comprehensive Quality
Strategies, and Revisions Related to
Third Party Liability’’ proposed rule
(‘‘June 1, 2015 proposed rule’’). As part
of the actuarial soundness proposals, we
proposed to define actuarially sound
capitation rates as those sufficient to
provide for all reasonable, appropriate,
and attainable costs that are required
under the terms of the contract,
including furnishing of covered services
and operation of the managed care plan
for the duration of the contract. Among
the proposals was a general rule that the
state may not direct the managed care
organization’s (MCO’s), prepaid
A. Summary of the Medicaid Managed
Care May 6, 2016 Final Rule
We finalized a policy to limit state
direction of payments, including passthrough payments, at § 438.6(c) and (d)
in the May 6, 2016 final rule (81 FR
27587 through 27592). Specifically,
under the final rule (81 FR 27588), we
defined pass-through payments at
§ 438.6(a) as any amount required by the
state (and considered in calculating the
actuarially sound capitation rate) to be
added to the contracted payment rates
paid by the MCO, PIHP, or PAHP to
hospitals, physicians, or nursing
facilities that is not for the following
purposes: A specific service or benefit
provided to a specific enrollee covered
under the contract; a provider payment
methodology permitted under
§ 438.6(c)(1)(i) through (iii) for services
and enrollees covered under the
contract; a subcapitated payment
*
*
*
*
*
[FR Doc. 2016–31823 Filed 1–17–17; 8:45 am]
BILLING CODE 6560–50–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
42 CFR Part 438
[CMS–2402–F]
RIN 0938–AT10
Medicaid Program; The Use of New or
Increased Pass-Through Payments in
Medicaid Managed Care Delivery
Systems
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Final rule.
AGENCY:
mstockstill on DSK3G9T082PROD with RULES
SUMMARY:
VerDate Sep<11>2014
16:39 Jan 17, 2017
Jkt 241001
PO 00000
Frm 00081
Fmt 4700
Sfmt 4700
5415
arrangement for a specific set of services
and enrollees covered under the
contract; graduate medical education
(GME) payments; or federally-qualified
health center (FQHC) or rural health
clinic (RHC) wrap around payments. We
noted that section 1903(m)(2)(A) of the
Social Security Act (the Act) requires
that capitation payments to managed
care plans be actuarially sound; we
interpret this requirement to mean that
payments under the managed care
contract must align with the provision
of services to beneficiaries covered
under the contract. We provided that
these pass-through payments are not
consistent with our regulatory standards
for actuarially sound rates because they
do not tie provider payments with the
provision of services. The final rule
contains a detailed description of the
policy rationale (81 FR 27587 through
27592).
In an effort to provide a smooth
transition for network providers, to
support access for the beneficiaries they
serve, and to provide states and
managed care plans with adequate time
to design and implement payment
systems that link provider
reimbursement with services covered
under the contract or associated quality
outcomes, we finalized transition
periods related to pass-through
payments for the specified provider
types to which states make most passthrough payments under Medicaid
managed care programs: Hospitals,
physicians, and nursing homes (81 FR
27590 through 27592). As finalized,
§ 438.6(d)(2) and (3) provide a 10-year
transition period for hospitals, subject to
limitations on the amount of passthrough payments. For MCO, PIHP, or
PAHP contracts beginning on or after
July 1, 2027, states will not be permitted
to require pass-through payments for
hospitals. The final rule also provides a
5-year transition period for pass-through
payments to physicians and nursing
facilities. For MCO, PIHP, or PAHP
contracts beginning on or after July 1,
2022, states will not be permitted to
require pass-through payments for
physicians or nursing facilities. These
transition periods provide states,
network providers, and managed care
plans significant time and flexibility to
integrate current pass-through payment
arrangements into allowable payment
structures under actuarially sound
capitation rates, including enhanced fee
schedules or the other approaches
consistent with § 438.6(c).
As finalized in the May 6, 2016 final
rule, § 438.6(d) limits the amount of
pass-through payments to hospitals as a
percentage of the ‘‘base amount,’’ which
is defined in paragraph (a) and
E:\FR\FM\18JAR1.SGM
18JAR1
Agencies
[Federal Register Volume 82, Number 11 (Wednesday, January 18, 2017)]
[Rules and Regulations]
[Pages 5409-5415]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-31823]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
40 CFR Part 180
[EPA-HQ-OPP-2015-0829; FRL-9956-85]
Acequinocyl; Pesticide Tolerances
AGENCY: Environmental Protection Agency (EPA).
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: This regulation establishes tolerances for residues of
acequinocyl in or on multiple commodities which are identified and
discussed later in this document. Interregional Project Number 4 (IR-4)
requested these tolerances under the Federal Food, Drug, and Cosmetic
Act (FFDCA).
DATES: This regulation is effective January 18, 2017. Objections and
requests for hearings must be received on or before March 20, 2017, and
must be filed in accordance with the instructions provided in 40 CFR
part 178 (see also Unit I.C. of the SUPPLEMENTARY INFORMATION).
ADDRESSES: The docket for this action, identified by docket
identification (ID) number EPA-HQ-OPP-2015-0829, is available at https://www.regulations.gov or at the Office of Pesticide Programs Regulatory
Public Docket (OPP Docket) in the Environmental Protection Agency
Docket Center (EPA/DC), West William Jefferson Clinton Bldg., Rm. 3334,
1301 Constitution Ave. NW., Washington, DC 20460-0001. The Public
Reading Room is open from 8:30 a.m. to 4:30 p.m., Monday through
Friday, excluding legal holidays. The telephone number for the Public
Reading Room is (202) 566-1744, and the telephone number for the OPP
Docket is (703) 305-5805. Please review the visitor instructions and
additional information about the docket available at https://www.epa.gov/dockets.
FOR FURTHER INFORMATION CONTACT: Michael Goodis, Registration Division
(7505P), Office of Pesticide Programs, Environmental Protection Agency,
1200 Pennsylvania Ave. NW., Washington, DC 20460-0001; main telephone
number: (703) 305-7090; email address: RDFRNotices@epa.gov.
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
You may be potentially affected by this action if you are an
agricultural producer, food manufacturer, or pesticide manufacturer.
The following list of North American Industrial Classification System
(NAICS) codes is not intended to be exhaustive, but rather provides a
guide to help readers determine whether this document applies to them.
Potentially affected entities may include:
Crop production (NAICS code 111).
Animal production (NAICS code 112).
Food manufacturing (NAICS code 311).
Pesticide manufacturing (NAICS code 32532).
[[Page 5410]]
B. How can I get electronic access to other related information?
You may access a frequently updated electronic version of EPA's
tolerance regulations at 40 CFR part 180 through the Government
Printing Office's e-CFR site at https://www.ecfr.gov/cgi-bin/text-idx?&c=ecfr&tpl=/ecfrbrowse/Title40/40tab_02.tpl.
C. How can I file an objection or hearing request?
Under FFDCA section 408(g), 21 U.S.C. 346a, any person may file an
objection to any aspect of this regulation and may also request a
hearing on those objections. You must file your objection or request a
hearing on this regulation in accordance with the instructions provided
in 40 CFR part 178. To ensure proper receipt by EPA, you must identify
docket ID number EPA-HQ-OPP-2015-0829 in the subject line on the first
page of your submission. All objections and requests for a hearing must
be in writing, and must be received by the Hearing Clerk on or before
March 20, 2017. Addresses for mail and hand delivery of objections and
hearing requests are provided in 40 CFR 178.25(b).
In addition to filing an objection or hearing request with the
Hearing Clerk as described in 40 CFR part 178, please submit a copy of
the filing (excluding any Confidential Business Information (CBI)) for
inclusion in the public docket. Information not marked confidential
pursuant to 40 CFR part 2 may be disclosed publicly by EPA without
prior notice. Submit the non-CBI copy of your objection or hearing
request, identified by docket ID number EPA-HQ-OPP-2015-0829, by one of
the following methods:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the online instructions for submitting comments. Do not submit
electronically any information you consider to be CBI or other
information whose disclosure is restricted by statute.
Mail: OPP Docket, Environmental Protection Agency Docket
Center (EPA/DC), (28221T), 1200 Pennsylvania Ave. NW., Washington, DC
20460-0001.
Hand Delivery: To make special arrangements for hand
delivery or delivery of boxed information, please follow the
instructions at https://www.epa.gov/dockets/contacts.html.
Additional instructions on commenting or visiting the docket, along
with more information about dockets generally, is available at https://www.epa.gov/dockets.
II. Summary of Petitioned-For Tolerance
In the Federal Register of May 19, 2016 (81 FR 31581) (FRL-9946-
02), EPA issued a document pursuant to FFDCA section 408(d)(3), 21
U.S.C. 346a(d)(3), announcing the filing of a pesticide petition (PP
5E8422) by Interregional Research Project Number 4 (IR-4), Rutgers
University, 500 College Rd. East, Suite 201 W, Princeton, NJ 08540. The
petition requested that 40 CFR 180.599 be amended by establishing
tolerances for residues of the insecticide acequinocyl in or on avocado
at 0.4 parts per million (ppm); bean, dry, seed at 0.03 ppm; vegetable,
cucurbit, group 9 at 0.2 ppm; tea, plucked leaves at 40 ppm; cherry
subgroup 12-12A at 1.0 ppm; fruit, citrus, group 10-10 at 0.20 ppm;
fruit, pome, group 11-10 at 0.40 ppm; nut, tree, group 14-12 at 0.02
ppm; and vegetable, fruiting, group 8-10 at 0.70 ppm. The petition also
requested that upon establishment of the above tolerances, to remove
the existing tolerances for cucumber at 0.15 ppm; melon, subgroup 9A at
0.15 ppm; cherry, sweet at 0.50 ppm; cherry, tart at 1.0 ppm; fruit,
citrus, group 10 at 0.20 ppm; fruit, pome, group 11 at 0.40 ppm; nut,
tree, group 14 at 0.02 ppm; pistachio at 0.02 ppm; vegetable, fruiting,
group 8 at 0.70 ppm; and okra at 0.70 ppm. That document referenced a
summary of the petition prepared by Arysta LifeScience, the registrant,
which is available in the docket, https://www.regulations.gov. Comments
were received on the notice of filing. EPA's response to these comments
is discussed in Unit IV.C.
Based upon review of the data supporting the petition, EPA has
modified the levels at which some of the tolerances are being
established. The reason for these changes is explained in Unit IV.D.
III. Aggregate Risk Assessment and Determination of Safety
Section 408(b)(2)(A)(i) of FFDCA allows EPA to establish a
tolerance (the legal limit for a pesticide chemical residue in or on a
food) only if EPA determines that the tolerance is ``safe.'' Section
408(b)(2)(A)(ii) of FFDCA defines ``safe'' to mean that ``there is a
reasonable certainty that no harm will result from aggregate exposure
to the pesticide chemical residue, including all anticipated dietary
exposures and all other exposures for which there is reliable
information.'' This includes exposure through drinking water and in
residential settings, but does not include occupational exposure.
Section 408(b)(2)(C) of FFDCA requires EPA to give special
consideration to exposure of infants and children to the pesticide
chemical residue in establishing a tolerance and to ``ensure that there
is a reasonable certainty that no harm will result to infants and
children from aggregate exposure to the pesticide chemical residue. . .
.''
Consistent with FFDCA section 408(b)(2)(D), and the factors
specified in FFDCA section 408(b)(2)(D), EPA has reviewed the available
scientific data and other relevant information in support of this
action. EPA has sufficient data to assess the hazards of and to make a
determination on aggregate exposure for acequinocyl including exposure
resulting from the tolerances established by this action. EPA's
assessment of exposures and risks associated with acequinocyl follows.
A. Toxicological Profile
EPA has evaluated the available toxicity data and considered its
validity, completeness, and reliability as well as the relationship of
the results of the studies to human risk. EPA has also considered
available information concerning the variability of the sensitivities
of major identifiable subgroups of consumers, including infants and
children.
The target organs of acequinocyl are the liver (hepatocyte
vacuolization, brown pigmented cells and perivascular inflammatory
cells in liver) and hematopoietic system (hemorrhage, increased
clotting factor times and increased platelet counts). There was no
evidence of neurotoxicity and immunotoxicity and there was no evidence
of carcinogenic potential in either the rat or mouse, or in the
genotoxicity and mutagenicity studies.
In rats and rabbits, there was no evidence of increased
quantitative or qualitative fetal susceptibility. In both species there
were clinical signs and gross necropsy findings seen in maternal
animals at similar or lower doses than those producing resorptions. In
rabbits, there were increased incidences of late resorptions at the
highest dose tested. In the rat two-generation reproductive toxicity
study, there was evidence of apparent increased quantitative postnatal
susceptibility. Offspring effects at the mid- and high-doses consisted
of swollen body parts, protruding eyes, clinical signs, delays in pupil
development, and increased mortality occurring mainly after weaning. No
parental effects were observed up to the highest dose tested; however,
hematological parameters, such as changes in partial and activated
partial
[[Page 5411]]
thromboplastin times, were not measured in parental animals and changes
in these parameters would have been expected at the same doses as
offspring effects based on rat studies in the acequinocyl toxicological
database. There were no effects on reproductive parameters.
Specific information on the studies received and the nature of the
adverse effects caused by acequinocyl as well as the no-observed-
adverse-effect-level (NOAEL) and the lowest-observed-adverse-effect-
level (LOAEL) from the toxicity studies can be found at https://www.regulations.gov in the document titled ``Acequinocyl. Human Health
Risk Assessment To Support the Petition for Tolerance for Residues in/
on Dry Beans, Cucurbit Vegetables, Group 9, Avocado and Tea (Without
U.S. Registration) and Crop Group Conversions for Citrus Fruit Group
10-10, Tree Nut Group 14-12, and Fruiting Vegetable Group 8-10'' at
page 30 in docket ID number EPA-HQ-OPP-2015-0829.
B. Toxicological Points of Departure/Levels of Concern
Once a pesticide's toxicological profile is determined, EPA
identifies toxicological points of departure (POD) and levels of
concern to use in evaluating the risk posed by human exposure to the
pesticide. For hazards that have a threshold below which there is no
appreciable risk, the toxicological POD is used as the basis for
derivation of reference values for risk assessment. PODs are developed
based on a careful analysis of the doses in each toxicological study to
determine the dose at which no adverse effects are observed (the NOAEL)
and the lowest dose at which adverse effects of concern are identified
(the LOAEL). Uncertainty/safety factors are used in conjunction with
the POD to calculate a safe exposure level--generally referred to as a
population-adjusted dose (PAD) or a reference dose (RfD)--and a safe
margin of exposure (MOE). For non-threshold risks, the Agency assumes
that any amount of exposure will lead to some degree of risk. Thus, the
Agency estimates risk in terms of the probability of an occurrence of
the adverse effect expected in a lifetime. For more information on the
general principles EPA uses in risk characterization and a complete
description of the risk assessment process, see https://www2.epa.gov/pesticide-science-and-assessing-pesticide-risks/assessing-human-health-risk-pesticides.
Since the last assessment for acequinocyl (Federal Register of
April 13, 2016, (81 FR 21752) (FRL-9944-34)), the endpoints for
acequinocyl were revisited and updated based upon the available data.
An acute dietary endpoint for the general population has been selected
to be consistent with current Agency practices. A summary of the
updated toxicological endpoints for acequinocyl used for human risk
assessment is shown in Table 1 of this unit.
Table 1--Summary of Toxicological Doses and Endpoints for Acequinocyl for Use in Human Health Risk Assessment
----------------------------------------------------------------------------------------------------------------
Point of departure
Exposure/scenario and uncertainty/ RfD, PAD, LOC for Study and toxicological effects
safety factors risk assessment
----------------------------------------------------------------------------------------------------------------
Acute dietary (General population NOAEL = 7.3 mg/kg/ Acute RfD = 0.073 Reproduction and fertility effects
including infants and children). day UFA = 10x. mg/kg/day. in rats Offspring LOAEL (M/F) =
UFH = 10x........... aPAD = 0.073 mg/kg/ 58.9 based on hemorrhagic
FQPA SF = 1x........ day. effects, swollen body parts,
protruding eyes, clinical signs,
delays in pupil development and
increased mortality post weaning.
----------------------------------------------------------------------------------------------------------------
Chronic dietary (All populations) NOAEL = 2.7 mg/kg/ Chronic RfD = 0.027 18-month carcinogenicity study in
day UFA = 10x. mg/kg/day. mice; LOAEL = 7.0 mg/kg/day based
UFH = 10x........... cPAD = 0.027 mg/kg/ on clinical chemistry and
FQPA SF = 1x........ day. microscopic non-neoplastic
lesions (brown pigmented cells
and perivascular inflammatory
cells in liver).
Dermal short-term (1 to 30 days). Dermal study NOAEL = LOC for MOE = 100.. 28-dermal toxicity in rats.
200 mg/kg/day. LOAEL (M/F) = 1000 mg/kg/day based
UFA = 10x........... on increased clotting factor
UFH = 10x........... times in males.
FQPA SF = 1x........
Cancer (Oral, dermal, inhalation) Classification: Not likely to be carcinogenic to humans.
----------------------------------------------------------------------------------------------------------------
FQPA SF = Food Quality Protection Act Safety Factor. LOAEL = lowest-observed-adverse-effect-level. LOC = level
of concern. mg/kg/day = milligram/kilogram/day. MOE = margin of exposure. NOAEL = no-observed-adverse-effect-
level. PAD = population-adjusted dose (a = acute, c = chronic). RfD = reference dose. UF = uncertainty factor.
UFA = extrapolation from animal to human (interspecies). UFH = potential variation in sensitivity among
members of the human population (intraspecies).
C. Exposure Assessment
1. Dietary exposure from food and feed uses. In evaluating dietary
exposure to acequinocyl, EPA considered exposure under the petitioned-
for tolerances as well as all existing acequinocyl tolerances in 40 CFR
180.599. EPA assessed dietary exposures from acequinocyl in food as
follows:
i. Acute exposure. Quantitative acute dietary exposure and risk
assessments are performed for a food-use pesticide, if a toxicological
study has indicated the possibility of an effect of concern occurring
as a result of a 1-day or single exposure.
Such effects were identified for acequinocyl. In estimating acute
dietary exposure, EPA used food consumption information from the United
States Department of Agriculture (USDA) 2003-2008 National Health and
Nutrition Examination Survey, What We Eat in America, (NHANES/WWEIA).
As to residue levels in food, EPA assumed tolerance level residues and
100 percent crop treated (PCT) for all proposed and registered uses.
ii. Chronic exposure. In conducting the chronic dietary exposure
assessment EPA used the food consumption data from the USDA 2003-2008
NHANES/WWEIA. As to residue levels in food, EPA assumed tolerance level
residues and 100 PCT for all proposed and registered uses.
iii. Cancer. Based on the data summarized in Unit III.A., EPA has
concluded that acequinocyl does not pose a cancer risk to humans.
Therefore,
[[Page 5412]]
a dietary exposure assessment for the purpose of assessing cancer risk
is unnecessary.
iv. Anticipated residue and PCT information. EPA did not use
anticipated residue or PCT information in the dietary assessment for
acequinocyl. Tolerance level residues and 100 PCT were assumed for all
food commodities.
2. Dietary exposure from drinking water. The Agency used screening
level water exposure models in the dietary exposure analysis and risk
assessment for acequinocyl in drinking water. These simulation models
take into account data on the physical, chemical, and fate/transport
characteristics of acequinocyl. Further information regarding EPA
drinking water models used in pesticide exposure assessment can be
found at https://www2.epa.gov/pesticide-science-and-assessing-pesticide-risks/about-water-exposure-models-used-pesticide.
Based on the Pesticide Root Zone Model/Exposure Analysis Modeling
System (PRZM/EXAMS), Provisional Cranberry Model, and Screening
Concentration in Ground Water (SCI-GROW) Model, the estimated drinking
water concentrations (EDWCs) of acequinocyl for acute exposures are
estimated to be 6.69 parts per billion (ppb) for surface water and 3.6
x 10-3 ppb for ground water, and for chronic exposures are
estimated to be 6.69 ppb for surface water and [gteqt]3.6 x
10-3 ppb for ground water.
Modeled estimates of drinking water concentrations were directly
entered into the dietary exposure model. For acute dietary risk
assessment, the water concentration value of 6.69 ppb was used to
assess the contribution to drinking water. For chronic dietary risk
assessment, the water concentration of value 6.69 ppb was used to
assess the contribution to drinking water.
3. From non-dietary exposure. The term ``residential exposure'' is
used in this document to refer to non-occupational, non-dietary
exposure (e.g., for lawn and garden pest control, indoor pest control,
termiticides, and flea and tick control on pets).
Acequinocyl is currently registered for the following uses that
could result in residential exposures: use on ornamentals for
landscapes, gardens, and trees. EPA assessed residential exposure using
the following assumptions: There is a potential for residential
exposure associated with handler (i.e., mixing, loading and applying);
however, all registered acequinocyl product labels with residential use
sites (e.g., ornamentals for landscapes, gardens, and trees) require
that handlers wear specific clothing (e.g., long-sleeve shirt/long
pants) and/or use personal protective equipment (PPE). Therefore, the
Agency has made the assumption that these products are not for
homeowner use, and has not conducted a quantitative residential handler
assessment.
Only short-term post-application dermal exposure is anticipated for
the registered residential uses. The quantitative exposure/risk
assessment for residential post-application exposures assessed dermal
exposures to adults for activities associated with gardening, dermal
exposures to children (6 to <11 years old) for activities associated
with playing in and around gardens and gardening, dermal exposures to
adults associated with handling trees and retail plants, and dermal
exposures to children (6 to <11 years old) for activities associated
with playing in and around trees and retail plants.
Further information regarding EPA standard assumptions and generic
inputs for residential exposures may be found at https://www2.epa.gov/pesticide-science-and-assessing-pesticide-risks/standard-operating-procedures-residential-pesticide.
4. Cumulative effects from substances with a common mechanism of
toxicity. Section 408(b)(2)(D)(v) of FFDCA requires that, when
considering whether to establish, modify, or revoke a tolerance, the
Agency consider ``available information'' concerning the cumulative
effects of a particular pesticide's residues and ``other substances
that have a common mechanism of toxicity.''
EPA has not found acequinocyl to share a common mechanism of
toxicity with any other substances, and acequinocyl does not appear to
produce a toxic metabolite produced by other substances. For the
purposes of this tolerance action, therefore, EPA has assumed that
acequinocyl does not have a common mechanism of toxicity with other
substances. For information regarding EPA's efforts to determine which
chemicals have a common mechanism of toxicity and to evaluate the
cumulative effects of such chemicals, see EPA's Web site at https://www2.epa.gov/pesticide-science-and-assessing-pesticide-risks/cumulative-assessment-risk-pesticides.
D. Safety Factor for Infants and Children
1. In general. Section 408(b)(2)(C) of FFDCA provides that EPA
shall apply an additional tenfold (10X) margin of safety for infants
and children in the case of threshold effects to account for prenatal
and postnatal toxicity and the completeness of the database on toxicity
and exposure unless EPA determines based on reliable data that a
different margin of safety will be safe for infants and children. This
additional margin of safety is commonly referred to as the FQPA Safety
Factor (SF). In applying this provision, EPA either retains the default
value of 10X, or uses a different additional safety factor when
reliable data available to EPA support the choice of a different
factor.
2. Prenatal and postnatal sensitivity. There is no evidence of an
increased quantitative or qualitative fetal susceptibility in rats or
rabbits. In isolation, there was evidence of increased quantitative
offspring susceptibility in the two-generation reproductive study;
however, but the concern is low since: (1) The effects in pups are well
characterized with a clear NOAEL; and (2) the effects are protected for
by the selected endpoints. Therefore, there are no residual
uncertainties for pre-/post-natal toxicity. Additionally, taking into
consideration the full database, there would be no susceptibility to
offspring since assessment of parental animals in the two-generation
reproductive toxicity study were limited. If additional evaluations had
been performed, including all hematological measurements, then it would
be expected that effects on the hematopoietic system observed in the
other oral rat studies would have been seen at the same doses eliciting
offspring effects. Therefore, using a weight-of-evidence approach that
puts the offspring findings in the two-generation reproductive toxicity
study in context with the full toxicological database, there is no
concern for susceptibility to offspring since parental toxicity would
be anticipated at the same dose as offspring effects.
3. Conclusion. EPA has determined that reliable data show the
safety of infants and children would be adequately protected if the
FQPA SF were reduced to 1x. That decision is based on the following
findings:
i. The toxicity database for acequinocyl is complete.
ii. There is no indication that acequinocyl is a neurotoxic
chemical and there is no need for a developmental neurotoxicity study
or additional UFs to account for neurotoxicity.
iii. There is no evidence of an increased quantitative or
qualitative fetal susceptibility in rats or rabbits, but in isolation
there was evidence of increased quantitative offspring susceptibility
in the two-generation reproductive study. However, the
[[Page 5413]]
concern is low for the reasons outlined above in section III.D.2.
iv. There are no residual uncertainties identified in the exposure
databases. The dietary food exposure assessments were performed based
on 100 PCT and tolerance-level residues. EPA made conservative
(protective) assumptions in the ground and surface water modeling used
to assess exposure to acequinocyl in drinking water. EPA used similarly
conservative assumptions to assess post-application exposure of
children. These assessments will not underestimate the exposure and
risks posed by acequinocyl.
E. Aggregate Risks and Determination of Safety
EPA determines whether acute and chronic dietary pesticide
exposures are safe by comparing aggregate exposure estimates to the
acute PAD (aPAD) and chronic PAD (cPAD). For linear cancer risks, EPA
calculates the lifetime probability of acquiring cancer given the
estimated aggregate exposure. Short-, intermediate-, and chronic-term
risks are evaluated by comparing the estimated aggregate food, water,
and residential exposure to the appropriate PODs to ensure that an
adequate MOE exists.
1. Acute risk. Using the exposure assumptions discussed in this
unit for acute exposure, the acute dietary exposure from food and water
to acequinocyl will occupy 71% of the aPAD for children 1-2 years old,
the population group receiving the greatest exposure.
2. Chronic risk. Using the exposure assumptions described in this
unit for chronic exposure, EPA has concluded that chronic exposure to
acequinocyl from food and water will utilize 70% of the cPAD for
children 1-2 years old, the population group receiving the greatest
exposure. Based on the explanation in Unit III.C.3., regarding
residential use patterns, chronic residential exposure to residues of
acequinocyl is not expected.
3. Short-term risk. Short-term aggregate exposure takes into
account short-term residential exposure plus chronic exposure to food
and water (considered to be a background exposure level). Acequinocyl
is currently registered for uses that could result in short-term
residential exposure, and the Agency has determined that it is
appropriate to aggregate chronic exposure through food and water with
short-term residential exposures to acequinocyl.
Using the exposure assumptions described in this unit for short-
term exposures, EPA has concluded the combined short-term food, water,
and residential exposures result in aggregate MOEs of 1200 for adults
and 890 for children 6-12 years old. Because EPA's level of concern for
acequinocyl is a MOE of 100 or below, these MOEs are not of concern.
4. Intermediate-term risk. Intermediate-term aggregate exposure
takes into account intermediate-term residential exposure plus chronic
exposure to food and water (considered to be a background exposure
level).
An intermediate-term adverse effect was identified; however,
acequinocyl is not registered for any use patterns that would result in
intermediate-term residential exposure. Intermediate-term risk is
assessed based on intermediate-term residential exposure plus chronic
dietary exposure. Because there is no intermediate-term residential
exposure and chronic dietary exposure has already been assessed under
the appropriately protective cPAD (which is at least as protective as
the POD used to assess intermediate-term risk), no further assessment
of intermediate-term risk is necessary, and EPA relies on the chronic
dietary risk assessment for evaluating intermediate-term risk for
acequinocyl.
5. Aggregate cancer risk for U.S. population. Based on the lack of
evidence of carcinogenicity in two adequate rodent carcinogenicity
studies, acequinocyl is not expected to pose a cancer risk to humans.
6. Determination of safety. Based on these risk assessments, EPA
concludes that there is a reasonable certainty that no harm will result
to the general population, or to infants and children from aggregate
exposure to acequinocyl residues.
IV. Other Considerations
A. Analytical Enforcement Methodology
Adequate enforcement methodology (two high-performance liquid
chromatography methods with tandem mass-spectroscopy detection (HPLC/
MS/MS) for determining residues in/on fruit and nut commodities (Morse
Methods Meth-133 and Meth-135) is available to enforce the tolerance
expression.
The method may be requested from: Chief, Analytical Chemistry
Branch, Environmental Science Center, 701 Mapes Rd., Ft. Meade, MD
20755-5350; telephone number: (410) 305-2905; email address:
residuemethods@epa.gov.
B. International Residue Limits
In making its tolerance decisions, EPA seeks to harmonize U.S.
tolerances with international standards whenever possible, consistent
with U.S. food safety standards and agricultural practices. EPA
considers the international maximum residue limits (MRLs) established
by the Codex Alimentarius Commission (Codex), as required by FFDCA
section 408(b)(4). The Codex Alimentarius is a joint United Nations
Food and Agriculture Organization/World Health Organization food
standards program, and it is recognized as an international food safety
standards-setting organization in trade agreements to which the United
States is a party. EPA may establish a tolerance that is different from
a Codex MRL; however, FFDCA section 408(b)(4) requires that EPA explain
the reasons for departing from the Codex level.
The Codex has not established any MRLs for acequinocyl.
C. Response to Comments
A comment was submitted by the Center for Biological Diversity and
was primarily concerned about EPA's consideration of the impacts of
acequinocyl on the environment, pollinators, and endangered species.
This comment is not relevant to the Agency's evaluation of safety of
the acequinocyl tolerances under section 408 of the FFDCA, which
requires the Agency to evaluate the potential harms to human health,
not effects on the environment.
Two other comments were submitted in response to the Notice of
Filing that stated, in part, that this chemical ``should not be used at
all in America or anywhere in the world'' and that ``no residue should
be permitted on any food or other plant.'' The Agency understands the
commenter's concerns and recognizes that some individuals believe that
pesticides should be banned on agricultural crops. However, the
existing legal framework provided by section 408 of the FFDCA states
that tolerances may be set when persons seeking such tolerances or
exemptions have demonstrated that the pesticide meets the safety
standard imposed by that statute. The citizens' comments appear to be
directed at the underlying statute and not EPA's implementation of it;
the citizens have made no contention that EPA has acted in violation of
the statutory framework.
D. Revisions to Petitioned-For Tolerances
The petitioned-for tolerance of 0.4 for residues on avocado is
being increased to 0.50 ppm as EPA corrected some residue levels in the
field trials for degradation during storage and declared two of the
trials to be replicates. The
[[Page 5414]]
data that EPA used in Organization for Economic Co-operation and
Development (OECD) Maximum Residue Limits (MRL) Tolerance Worksheet for
avocado was thus slightly different from the petitioner's data. The
tolerance level of 0.15 ppm for residues in dry beans is based upon the
OECD MRL tolerance worksheet. The difference is based on EPA using
slightly different residue levels that were corrected for degradation
during storage. The tolerance level of 0.30 ppm for residues in/on
cucurbit vegetables is based upon the OECD MRL tolerance worksheet. The
difference is based on EPA using slightly different residue levels that
were corrected for degradation during storage. The data that EPA used
in MRL tolerance spreadsheet for summer squash was slightly different
from the petitioner's data. Concerning the crop group conversions, the
tolerance level for residues in/on citrus fruit was modified to be
harmonized with the Canadian MRL.
V. Conclusion
Therefore, tolerances are established for residues of acequinocyl,
including its metabolites and degradates, in or on avocado at 0.50 ppm;
bean, dry, seed at 0.15 ppm; cherry, subgroup 12-12A at 1.0 ppm; fruit,
citrus, group 10-10 at 0.35 ppm; fruit, pome, group 11-10 at 0.40 ppm;
nut, tree, group 14-12 at 0.02 ppm; tea, plucked leaves at 40 ppm;
vegetable, cucurbit, group 9 at 0.30 ppm; and vegetable, fruiting,
group 8-10 at 0.70 ppm. In addition, the existing tolerances on cherry,
sweet; cherry, tart; cucumber; fruit, citrus, group 10; fruit, pome,
group 11; melon, subgroup 9A; nut, tree, group 14; okra; pistachio; and
vegetable, fruiting, group 8 are removed as unnecessary since they are
now covered by the new tolerances.
VI. Statutory and Executive Order Reviews
This action establishes tolerances under FFDCA section 408(d) in
response to a petition submitted to the Agency. The Office of
Management and Budget (OMB) has exempted these types of actions from
review under Executive Order 12866, entitled ``Regulatory Planning and
Review'' (58 FR 51735, October 4, 1993). Because this action has been
exempted from review under Executive Order 12866, this action is not
subject to Executive Order 13211, entitled ``Actions Concerning
Regulations That Significantly Affect Energy Supply, Distribution, or
Use'' (66 FR 28355, May 22, 2001) or Executive Order 13045, entitled
``Protection of Children from Environmental Health Risks and Safety
Risks'' (62 FR 19885, April 23, 1997). This action does not contain any
information collections subject to OMB approval under the Paperwork
Reduction Act (PRA) (44 U.S.C. 3501 et seq.), nor does it require any
special considerations under Executive Order 12898, entitled ``Federal
Actions to Address Environmental Justice in Minority Populations and
Low-Income Populations'' (59 FR 7629, February 16, 1994).
Since tolerances and exemptions that are established on the basis
of a petition under FFDCA section 408(d), such as the tolerance in this
final rule, do not require the issuance of a proposed rule, the
requirements of the Regulatory Flexibility Act (RFA) (5 U.S.C. 601 et
seq.), do not apply.
This action directly regulates growers, food processors, food
handlers, and food retailers, not States or tribes, nor does this
action alter the relationships or distribution of power and
responsibilities established by Congress in the preemption provisions
of FFDCA section 408(n)(4). As such, the Agency has determined that
this action will not have a substantial direct effect on States or
tribal governments, on the relationship between the national government
and the States or tribal governments, or on the distribution of power
and responsibilities among the various levels of government or between
the Federal Government and Indian tribes. Thus, the Agency has
determined that Executive Order 13132, entitled ``Federalism'' (64 FR
43255, August 10, 1999) and Executive Order 13175, entitled
``Consultation and Coordination with Indian Tribal Governments'' (65 FR
67249, November 9, 2000) do not apply to this action. In addition, this
action does not impose any enforceable duty or contain any unfunded
mandate as described under Title II of the Unfunded Mandates Reform Act
(UMRA) (2 U.S.C. 1501 et seq.).
This action does not involve any technical standards that would
require Agency consideration of voluntary consensus standards pursuant
to section 12(d) of the National Technology Transfer and Advancement
Act (NTTAA) (15 U.S.C. 272 note).
VII. Congressional Review Act
Pursuant to the Congressional Review Act (5 U.S.C. 801 et seq.),
EPA will submit a report containing this rule and other required
information to the U.S. Senate, the U.S. House of Representatives, and
the Comptroller General of the United States prior to publication of
the rule in the Federal Register. This action is not a ``major rule''
as defined by 5 U.S.C. 804(2).
List of Subjects in 40 CFR Part 180
Environmental protection, Administrative practice and procedure,
Agricultural commodities, Pesticides and pests, Reporting and
recordkeeping requirements.
Dated: December 15, 2016.
Daniel J. Rosenblatt,
Acting Director, Registration Division, Office of Pesticide Programs.
Therefore, 40 CFR chapter I is amended as follows:
PART 180--[AMENDED]
0
1. The authority citation for part 180 continues to read as follows:
Authority: 21 U.S.C. 321(q), 346a and 371.
0
2. In Sec. 180.599, in the table in paragraph (a);
0
a. Add alphabetically the entries ``Avocado''; ``Bean, dry, seed'';
``Cherry, subgroup 12-12A''; ``Fruit, citrus, group 10-10''; ``Fruit,
pome, group 11-10''; ``Nut, tree, group 14-12''; ``Tea, plucked
leaves'' (and a footnote); ``Vegetable, cucurbit, group 9''; and
``Vegetable, fruiting, group 8-10''; and
0
b. Remove the entries for ``cherry, sweet''; ``cherry, tart'';
``cucumber''; ``fruit, citrus, group 10''; ``fruit, pome, group 11'';
``melon, subgroup 9A''; ``nut, tree, group 14''; ``okra'';
``pistachio''; and ``vegetable, fruiting, group 8'' from the table in
paragraph (a).
The additions read as follows:
Sec. 180.599 Acequinocyl; tolerances for residues.
(a) * * *
------------------------------------------------------------------------
Parts per
Commodity million
------------------------------------------------------------------------
* * * *
Avocado.................................................... 0.50
Bean, dry, seed............................................ 0.15
* * * *
Cherry, subgroup 12-12A.................................... 1.0
* * * *
Fruit, citrus, group 10-10................................. 0.35
Fruit, pome, group 11-10................................... 0.40
* * * *
Nut, tree, group 14-12..................................... 0.02
* * * *
Tea, plucked leaves \1\.................................... 40
Vegetable, cucurbit, group 9............................... 0.30
Vegetable, fruiting, group 8-10............................ 0.70
------------------------------------------------------------------------
\1\ There are no U.S. registrations as of January 18, 2017 for use on
tea.
[[Page 5415]]
* * * * *
[FR Doc. 2016-31823 Filed 1-17-17; 8:45 am]
BILLING CODE 6560-50-P